Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04535895

Simultaneous Integrated Boost Technique in Breast Cancer Radiotherapy

Simultaneous Integrated Boost (SIB) Technique in the Adjuvant Radiotherapy of Breast Cancer Patients.

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Medical University of Graz · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Adjuvant radiotherapy after breast conserving surgery has been shown to improve both local control and overall survival. Dose escalation of the tumor bed by addition of a boost after whole breast radiotherapy reduces the risk of local recurrence in invasive breast cancer. Simultaneous integrated boost (SIB) techniques have been shown to provide more conformal treatment plans than conventional sequential boost, in addition, SIB enables a reduction in the overall treatment time by 1 week compared to conventional boost techniques. The proposed study is aimed at evaluating radiation-induced toxicity in patients treated with breast-conserving surgery in combination with radiotherapy using SIB technique.

Conditions

Interventions

TypeNameDescription
RADIATIONSimultaneous integrated boostAdjuvant breast cancer irradiation including simultaneous integrated boost

Timeline

Start date
2020-04-16
Primary completion
2022-08-31
Completion
2025-08-31
First posted
2020-09-02
Last updated
2022-10-12

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT04535895. Inclusion in this directory is not an endorsement.